Metabolic syndrome and bone metabolism: The Camargo Cohort Study

Menopause

Volumn 17, Issue 5, 2010, Pages 955-961

  Hernández, José L ^a   Olmos, José M ^a   Pariente, Emilio ^b   Martínez, Josefina ^a   Valero, Carmen ^a   García Velasco, Pilar ^b   Nan, Daniel ^a   Llorca, Javier ^a   González Macías, Jesús ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b Centro de Salud BJosé Barros   (Spain)

Author keywords

Bone metabolism; Bone mineral density; Bone remodeling markers; Calciotropic hormones; Metabolic syndrome; Nonvertebral fractures; Vertebral fractures

Indexed keywords

25 HYDROXYVITAMIN D; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; PARATHYROID HORMONE; PROPEPTIDE TYPE I COLLAGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY MASS; BONE DENSITY; BONE METABOLISM; BONE REMODELING; BONE TURNOVER; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRACTURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONVERTEBRA FRACTURE; VERTEBRA FRACTURE; WAIST CIRCUMFERENCE;

AGED; BODY MASS INDEX; BONE DENSITY; CALCIFEDIOL; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OSTEOPOROSIS; PARATHYROID HORMONE; PREVALENCE; SEX FACTORS; SPAIN; SPINAL FRACTURES;

EID: 77957699588     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181e39a15     Document Type: Article

References (35)

1. Ash-Bernal R, Peterson LR. The cardiometabolic syndrome and cardiovascular disease. J Cardiometab Syndr 2006;1:25-28.
2. Grundy SM, Brewer HB Jr, Cleeman JI, et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433-438.
3. Lorenzo C, Williams K, Hunt KJ, et al. Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: the San Antonio Heart Study. Diabetes Care 2006;29:625-630.
4. Zanchetti A, Hennig M, Baurecht H, et al. Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness. J Hypertens 2007;25:2463-2470.
5. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005;28:2745-2749.
6. Balkau B, Charles MA, Drivsholm T, et al. European Group for the Study of Insulin Resistance (EGIR). Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 2002;28:364-376.
7. Rosen CJ. Clinical practice. Postmenopausal osteoporosis. N Engl J Med 2005;353:595-603.
8. von Muhlen D, Safii S, Jassal SK, et al. Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study. Osteoporos Int 2007;18:1337-1344.
9. Kinjo M, Setoguchi S, Solomon DH. Bone mineral density in adults with the metabolic syndrome: analysis in a population-based U.S. sample. J Clin Endocrinol Metab 2007;92:4161-4164.
10. Hwang DK, Choi HJ. The relationship between low bone mass and metabolic syndrome in Korean women. Osteoporos Int 2010;21:425-431.
11. Park KK, Kim SJ, Moon ES. Association between bone mineral density and metabolic syndrome in postmenopausal Korean women. Gynecol Obstet Invest 2009;69:145-152.
12. Boyanov M, Bakalov D, Boneva Z. Bone mineral density in men with and without the metabolic syndrome. Aging Male 2009;12:62-65.
13. Yaturu S, Humphrey S, Landry C, Jain SK. Decreased bone mineral density in men with metabolic syndrome alone and with type 2 diabetes. Med Sci Monit 2009;15:CR5-CR9.
14. Yamaguchi T, Kanazawa I, Yamamoto M, et al. Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetes. Bone 2009;45:174-179.
15. Mart́nez J, Olmos JM, Hernández JL, et al. Bone turnover markers in Spanish postmenopausal women: the Camargo Cohort Study. Clin Chim Acta; 2009. 409:70-74.
16. Hernández JL, Olmos JM, Ramos C, et al. Serum lipids and bone metabolism in Spanish men: the Camargo Cohort Study. Endocr J 2010;57: 51-60.
17. Berry EM, Gupta MM, Turner SJ, et al. Variations in plasma calcium with induced changes in plasma specific gravity, total protein, and albumin. Br Med J 1973;4:640-643.
18. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470.
19. Garnero P, Vergnaud P, Hoyle N. Evaluation of a fully automated serum assay for total N-terminal propeptide of type I collagen in postmeno-pausal osteoporosis. Clin Chem 2008;54:188-196.
20. Garnero P, Borel O, Delmas PD. Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis. Clin Chem 2001;47:694-702.
21. Riancho JA, Valero C, Hernández JL, et al. Biomechanical indices of the femoral neck estimated from the standard DXA output: age and sex-related differences. J Clin Densitom 2007;10:39-45.
22. Genant HK, Jergas M, Palermo L, et al. Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis: the Study of Osteoporotic Fractures Research Group. J Bone Miner Res 1996;11:984-996.
23. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-1197.
24. Lidfeldt J, Holmdahl L, Samsioe G, et al. The influence of hormonal status and features of the metabolic syndrome on bone density: a population-based study of Swedish women aged 50 to 59 years. The Women's Health in the Lund Area study. Metabolism 2002;51:267-270.
25. Hanley DA, Brown JP, Tenenhouse A, et al. Canadian Multicentre Osteoporosis Study Research Group. Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: cross-sectional results from the Canadian Multicentre Osteoporosis Study. J Bone Miner Res 2003;18: 784-790.
26. Cappuccio FP, Meilahn E, Zmuda JM, et al. High blood pressure and bone-mineral loss in elderly white women: a prospective study. Study of Osteoporotic Fractures Research Group. Lancet 1999;354:971-975.
27. Kume S, Kato S, Yamagishi S, et al. Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone. J Bone Miner Res 2005; 20:1647-1658.
28. Ahmed LA, Schirmer H, Berntsen GK, et al. Features of the metabolic syndrome and the risk of non-vertebral fractures: the Tromso study. Osteoporos Int 2006;17:426-432.
29. Olmos JM, Vázquez LA, Amado JA, et al. Mineral metabolism in obese patients following vertical banded gastroplasty. Obes Surg 2008; 18:197-203.
30. Worstman J, Matsuoka LY, Chen TC, et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000;72:690-693.
31. Arunabh S, Pollack S, Yeh J, et al. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab 2003;88:157-161.
32. Targher G, Bertolini L, Padovani R, et al. Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol 2006;65:593-597. (Pubitemid 44583818)
33. Ford ES, Ajani UA, McGuire LC, et al. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005; 28:1228-1230.
34. Oz SG, Guven GS, Kilicarslan A, et al. Evaluation of bone metabolism and bone mass in patients with type-2 diabetes mellitus. J Natl Med Assoc 2006;98:1598-1604.
35. Delgado-Rodŕ?guez M, Llorca J. Bias. J Epidemiol Community Health. 2004;58:635-641.